The Institute [http://www.cemm.at/]
The CeMM Research Center for Molecular Medicine is an international and interdisciplinary research institute of the Austrian Academy of Sciences. Driven by medical needs, CeMM integrates basic research and clinical expertise to pursue innovative diagnostic and therapeutic approaches focused on cancer, inflammation and immune disorders. CeMM is located in a new tailor-made building at the center of the Vienna Medical University campus, within walking distance of Vienna’s historical city center. According to a study by “The Scientist”, CeMM is ranked as the best European place to work in Academia 2012, internationally CeMM appears at the fourth place, see: http://the-scientist.com/2012/08/01/best-places-to-work-academia-2012. Vienna is frequently ranked the world’s best city to live. It is a United Nations city with a large English-speaking community. The official language at CeMM is English, as more than 30 different nationalities are represented.
The Biomedical Sequencing Facility
The CeMM and the Medical University of Vienna (MUV) recently joined forces and launched the Biomedical Sequencing Facility (BSF), which is coordinated by CeMM Principal Investigator and MUV Guest Professor Dr. Christoph Bock. The goals of the BSF are to foster biomedical research and to catalyze the advent of genomic medicine in Vienna and Austria. The BSF is currently equipped with two Illumina HiSeq 2000 sequencers; and further machine purchases are planned for 2012/2013. It is supported by a powerful scientific computing cluster, which is upgraded annually to keep pace with strongly increasing amounts of biomedical data. Furthermore, project-based access to the Vienna Scientific Cluster (a top-100 supercomputer) provides ample resources for large-scale integrative analyses and bioinformatic methods development. The BSF supports various experimental protocols for biomedical research, including genome and exome sequencing, epigenome mapping, and transcriptome profiling. Furthermore, the BSF collaborates with clinical labs at the MUV toward establishing genome sequencing as part of routine clinical diagnostics.
Associated Labs at CeMM
• The Medical Epigenomics lab is headed by Dr. Christoph Bock and studies the contribution of epigenetic defects to cancer, utilizing both experimental and computational methods (http://medical-epigenomics.org/ and http://www.cemm.oeaw.ac.at/?id=235).
• The Pediatric Immunogenomics lab is headed by Dr. Kaan Boztug, focusing on the work on the genetics and genomics of primary immundeficiencies, congenital bone marrow failure syndromes and malignant disorders of childhood (http://www.cemm.oeaw.ac.at/index.php?id=186).
• The Cancer Genomics lab is headed by Dr. Robert Kralovics, investigating the genomic basis of chronic and acute hematological malignancies (http://www.cemm.oeaw.ac.at/index.php?id=33).
• In addition to these three labs (which are physically co-located with the BSF), the facility maintains a broad network of collaborators across Vienna’s medical campus as well as nationally and internationally.